Nutriflex Omega Special Novo (Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin)

The mixture supplies a balanced profile of essential and non‑essential amino acids directly into the bloodstream. These amino acids serve as building blocks for protein synthesis, help maintain nitrogen balance, support tissue repair, and provide energy substrates, thereby addressing the metabolic needs of patients unable to ingest nutrients orally.

The dose of Nutriflex Omega Special Novo is individualized by the prescribing clinician based on the patient’s weight, metabolic requirements, and clinical condition. Healthcare professionals calculate the appropriate infusion rate and total daily amount to meet the patient’s protein and nitrogen needs.

Safety data for Nutriflex Omega Special Novo in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician in consultation with obstetric specialists.

To order Nutriflex Omega Special Novo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Nutriflex Omega Special Novo offers a comprehensive blend of ten essential amino acids formulated for balanced nitrogen delivery. Compared with single‑component or less‑balanced amino acid solutions, it aims to more closely mimic physiological amino acid ratios, potentially reducing the need for additional supplementation and supporting more efficient protein synthesis.

The product must be stored at 2‑8 °C, protected from light, and kept in its original container. It should not be frozen or shaken vigorously. Before use, inspect the solution for any particulate matter or discoloration and ensure aseptic technique during preparation and administration.

Nutriflex Omega Special Novo is administered intravenously, typically via a central or peripheral venous catheter. The infusion rate is determined by the prescribing clinician and may be adjusted based on the patient’s metabolic response, electrolyte status, and overall clinical condition.

Serious risks include severe hypersensitivity reactions such as anaphylaxis, metabolic acidosis, hyperammonemia, significant electrolyte imbalances, and renal or hepatic dysfunction. Patients should be closely monitored for signs of these events, and therapy should be discontinued immediately if they occur.

Nutriflex Omega Special Novo should be avoided in patients with known hypersensitivity to any of its amino acid components, those with uncontrolled electrolyte disturbances, severe renal or hepatic failure, or metabolic disorders that contraindicate high amino acid loads, unless a specialist determines that benefits outweigh risks.